Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.35 |
| ▸ | GABRD | O14764 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.35 |
| ▸ | GABRE | P78334 | 2/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.35 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.35 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.35 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4278466 | 0.88 | LMNA (0.45) | LMNAKDM5BPOLBCYP1A2GABRP | |
| SCHEMBL3079818 | 0.88 | KDM5B (0.37) | LMNAKDM5BPOLBCYP1A2GABRP | |
| SCHEMBL19611140 | 0.86 | ALDH1A1 (0.36) | KDM5BPOLBCYP1A2GABRPGABRD | |
| SCHEMBL2066277 | 0.79 | GABRP (0.40) | LMNAKDM5BPOLBCYP1A2GABRP | |
| SCHEMBL27268730 | 0.77 | GRM1 (0.41) | LMNAKDM5BPOLBCYP1A2GABRP | |
| SCHEMBL6448117 | 0.76 | CYP1A2 (0.42) | KDM5BPOLBCYP1A2GABRPGABRD | |
| SCHEMBL28238364 | 0.76 | CYP1A2 (0.42) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL5539723 | 0.76 | ALDH1A1 (0.39) | LMNAKDM5BPOLBCYP1A2GABRP | |
| SCHEMBL5695797 | 0.75 | POLB (0.44) | LMNAKDM5BPOLBALDH1A1KDM4E | |
| SCHEMBL8603134 | 0.75 | ACE2 (0.40) | POLBCYP1A2GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050244365-A1 | Methods, compositions, formulations, and uses of cellulose and acrylic-based polymers | NOVAFLUX BIOSCIENCES, INC. (US) | 2005-11-03 | — | — | US | claimed |
| US-20070148124-A1 | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases | NOVAFLUX INC. | 2007-06-28 | — | — | US | disclosed |
| EP-1749041-A2 | CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES | Nova Flux Biosciences, Inc. (US) | 2007-02-07 | — | — | EP | disclosed |
| WO-2005111112-A2 | CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES | NOVA FLUX BIOSCIENCES, INC. (US) | 2005-11-24 | — | — | WO | disclosed |
| US-20050244365-A1 | Methods, compositions, formulations, and uses of cellulose and acrylic-based polymers | NOVAFLUX BIOSCIENCES, INC. (US) | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050244365-A1 | Methods, compositions, formulations, and uses of cellulose and acrylic-based polymers | DNA2, DNASE1, SMC2 | LMNA 2674/4885KDM5B 3686/4885POLB 40/4885 |
| US-20070148124-A1 | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases | ALG1, CHIT1, CHIA | LMNA 2751/4885KDM5B 838/4885POLB 3112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.